International Emergency Economic Powers Act

Data

August 6, 2026

Analysing the compliance imperatives for both US pharma and the strategic considerations for Chinese biotech navigating the cross-border environment.

“GRIP is invaluable for updates on SEC and FINRA actions.”

Unlimited access for 4 weeks. No payment details required. Start free trial